Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02635724. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Single-arm, Open-label, Study to Evaluate the Safety, Pharmacokinetics and Effectiveness of Intravenous Peramivir in Elderly Subjects With Acute Uncomplicated Influenza Infection and in Subjects With Acute Uncomplicated Influenza Infection at Higher Risk for Influenza Complications
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of 600 mg IV peramivir in the treatment of elderly subjects with acute uncomplicated influenza infection and in subjects with acute uncomplicated influenza infection at higher risk for influenza complications. All subjects will receive IV peramivir.
Study identification
- NCT ID
- NCT02635724
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 74 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2015 (Type not available)
- Primary completion
- Apr 2018 (Actual)
- Completion
- Sep 2018 (Actual)
- Last update posted
- Mar 23, 2021
2015 – 2018
United States locations
- U.S. sites
- 15
- U.S. states
- 7
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Peramivir Investigational Site | Brooksville | Florida | — | — |
| Peramivir Investigational Site | Lakeland | Florida | — | — |
| Peramivir Investigational Site | Miami | Florida | — | — |
| Peramivir Investigational Site | St. Petersburg | Florida | — | — |
| Peramivir Investigational Site | Tampa | Florida | — | — |
| Peramivir investigative site | Indianapolis | Indiana | — | — |
| Peramivir investigative site | Detroit | Michigan | — | — |
| Peramivir Investigational Site | Dayton | Ohio | — | — |
| Peramivir investigative site | Smithfield | Pennsylvania | — | — |
| Peramivir Investigational Site | Houston | Texas | — | — |
| Peramivir Investigative Site | San Antonio | Texas | — | — |
| Peramivir investigative site | Splendora | Texas | — | — |
| Peramivir Investigational Site | Draper | Utah | — | — |
| Peramivir Investigational Site | Salt Lake City | Utah | — | — |
| Peramivir investigative site | South Jordan | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02635724, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2021 · Synced Nov 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.